Methylenetetrahydrofolate reductase and methionine synthase polymorphisms and risk of bladder cancer in a Tunisian population

Cancer Genetics and Cytogenetics

Volumn 176, Issue 1, 2007, Pages 48-53

  Ouerhani, Slah ^a   Oliveira, Elisabete ^b   Marrakchi, Raja ^a   Ben Slama, Mohamed R ^c   Sfaxi, Mohamed ^c   Ayed, Mohsen ^c   Chebil, Mohamed ^c   Amorim, António ^b   El Gaaied, Amel Benammar ^a   Prata, Maria João ^b  

^a FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

^b UNIVERSITY OF PORTO   (Portugal)

^c CHARLES NICOLLE HOSPITAL   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); METHIONINE SYNTHASE;

AGED; ALLELE; ARTICLE; BLADDER CANCER; CANCER RISK; CASE CONTROL STUDY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME ACTIVITY; FEMALE; GENE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHIONINE SYNTHASE GENE; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; PRIORITY JOURNAL; RISK; STATISTICAL SIGNIFICANCE; TUNISIA;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); ODDS RATIO; POLYMORPHISM, GENETIC; RISK; TUNISIA; URINARY BLADDER NEOPLASMS;

EID: 34250354391     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2007.03.007     Document Type: Article

References (29)

1. Greenlee R.T., Hill-Harmon M.B., Murray T., and Thun M. Cancer statistics. CA Cancer J Clin 51 (2001) 15-36
2. Sellami A., Jlidi R., Hsaïri M., and Achour N. Registre du cancer du sud Tunisie 1997. Hôpital Habib Bourguiba 2 (2000) 32-35
3. Hainaut P., and Pfeifer G.P. Patterns of p53 G→T transversions in lung cancers reflect the primary mutagenic signature of DNA damage by tobacco smoke. Carcinogenesis 22 (2001) 367-374
4. Knowles M.A. The genetics of transitional cell carcinoma: progress and potential clinical application. Br J Urol Int 84 (1999) 412-427
5. Florl A.R., Loewer R., Schmitz-Dräger B.J., and Schulz W.A. DNA methylation and expression of L1 LINE and HERV-K provirus sequences in urothelial and renal cell carcinoma. Br J Cancer 80 (1999) 1312-1321
6. Rosenblatt D. Clinically important genes: methylenetetrahydrofolate reductase. Clin Invest Med 24 (2001) 56-59
7. Robien K., and Ulrich C.M. 5,10-methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE mini-review. Am J Epidemiol 157 (2003) 571-582
8. Heijmans B.T., Boer J.M., Suchiman H.E., Cornelisse C.J., Westendorp R.G., Kromhout D., Feskens E.J., and Slagboom P.E. A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer. Cancer Res 63 (2003) 1249-1253
9. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J., Den Heijer M., Kluijtmans L.A., Van Den Heuvel L.P., and Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10 (1995) 111-113
10. Weisberg I., Tran P., Christensen B., Sibani S., and Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64 (1998) 169-172
11. Vander Put N.M., Gabreels F., Stevens E.M., Smeitink J.A., Trijbels F.J., Eskes T.K., van den Heuvel L.P., and Blom H.J. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?. Am J Hum Genet 62 (1998) 1044-1051
12. Harmon D.L., Shields D.C., Woodside J.V., Maeda H., and Kohno N. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol 17 (1999) 298-309
13. Leclerc D., Campeau E., Goyette P., Adjalla C.E., Christensen B., Ross M., Eydoux P., Rosenblatt D.S., Rozen R., and Gravel R.A. Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. Hum Mol Genet 5 (1996) 1967-1974
14. Chen J., Ma J., Stampfer M.J., Palomeque C., Selhub J., and Hunter D.J. Linkage disequilibrium between the 6774T and 1298A→C polymorphisms in human methylenetetrahydrofolate reductase gene and their contributions to risk of colorectal cancer. Pharmacogenetics 12 (2002) 339-342
15. Lin J., Spitz M.R., Wang Y., Schabath M.B., Gorlov I.P., Hernandez L.M., Pillow P.C., Grossman H.B., and Wu X. Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study. Carcinogenesis 25 (2004) 1639-1647
16. Moore L.E., Wiencke J.K., Bates M.N., Zheng S., Rey O.A., and Smith A.H. Investigation of genetic polymorphisms and smoking in a bladder cancer case-control study in Argentina. Cancer Lett 211 (2004) 199-207
17. Kimura F., Florl A.R., Steinhoff C., Golka K., Willers R., Seifert H.H., and Schulz W.A. Polymorphic methyl group metabolism genes in patients with transitional cell carcinoma of the urinary bladder. Mutat Res 458 (2001) 49-54
18. Sanyal S., Festa F., Sakano S., Zhang Z., Steineck G., Norming U., Wijkstrom H., Larsson P., Kumar R., and Hemminki K. Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 25 (2004) 729-734
19. Karagas M.R., Park S., Nelson H.H., Andrew A.S., Mott L., Schned A., and Kelsey K.T. Methylenetetrahydrofolate reductase (MTHFR) variants and bladder cancer: a population-based case-control study. Int J Hyg Environ Health 208 (2005) 321-327
20. Sambrook J., Fritsch E.F., and Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd edition (1989), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
21. Paz M.F., Avila S., Fraga M.F., Pollan M., Capella G., Peinada M.A., Sanchez-Cespedes M., Herman J.G., and Estellar M. Germ-line variants in methyl-group metabolisms genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Res 62 (2002) 4519-4524
22. Oliveira E., Alves S., Quental S., Ferreira F., Norton L., Costa V., Amorim A., and Prata M.J. The MTHFR C677T and A1298C polymorphisms and susceptibility to childhood acute lymphoblastic leukemia in Portugal. J Pediatr Hematol Oncol 27 (2005) 425-429
23. O'Gorman T.W., and Woolson R.F. The effect of category choice on the odds ratio and several measures of association in case-control studies. Commun Stat 22 (1993) 1157-1171
24. Stegmann K., Ziegler A., Ngo E.T., Kohlschmidt N., Schroter B., Ermert A., and Koch K.C. Linkage disequilibrium of MTHFR genotypes 677C/T-1298A/C in the German population and association studies in probands with neural tube defects (NTD). Am J Med Genet 87 (1999) 23-29
25. Mtiraoui N, Ezzidi I, Chaieb M, Marmouche H, Aouni Z, Chaieb A, Mahjoub T, Vaxillaire M, Almawi WY. MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients. Diabetes Res Clin Pract 2007;75:99-106.
26. Ameen G., Irani-Hakime N., Fawaz N.A., Mahjoub T., and Almawi W.Y. An Arab selective gradient in the distribution of factor VG1691A (Leiden), prothrombin G20210A, and methylenetetrahydrofolate reductase (MTHFR) C677T. J Thromb Haemost 3 (2005) 2126-2127
27. Goodman M.T., McDuffie K., Hernandez B., Wilkens L.R., Bertram C.C., Killeen J., Marchand L., Selhub J., Murphy S., and Donlon T.A. Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with risk of cervical dysplasia. Cancer Epidemiol Biomark Prev 10 (2001) 1275-1280
28. Shen H., Xu Y., Zheng Y., Qian Y., Yu R., Qin Y., Wang X., Spitz M.R., and Wei Q. Polymorphisms of 5,10 methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study. Int J Cancer 95 (2001) 332-336
29. Song C., Xing D., Tan W., Wei Q., and Lin D. Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res 61 (2001) 3272-3275